Table 4.
First line treatments | Overall Italy (n=300) |
Italian areas
|
Causes of acute cough
|
||||||
---|---|---|---|---|---|---|---|---|---|
Northern (n=90) |
Central (n=66) |
Southern (n=144) |
Allergic rhinitis/asthma (n=44) | Viral infections (n=134) |
URTIs (n=92) |
LRTIs (n=22) |
Others (n=8) |
||
None | 24 (8.0%) | 2 (2.2%), p=0.016 | 10 (15.2%), p=0.004 | 12 (8.3%), p=0.616 | 0, p=0.314 | 20 (14.9%), p=0.046 | 2 (2.2%), p=0.194 | 0, p=0.517 | 2 (25.0%), p=0.015 |
Aerosol therapy | 79 (26.3%) | 21 (23.3%), p=0.904 | 12 (18.2%), p=0.211 | 46 (31.9%), p=0.134 | 18 (40.9%), p=0.005 | 27 (20.1%), p=0.388 | 30 (32.6%), p=0.262 | 4 (18.2%), p=0.781 | 0, p=0.155 |
Oral corticosteroids | 30 (10.0%) | 10 (11.1%), p=0.250 | 3 (4.5%), p=0.102 | 17 (11.8%), p=0.292 | 6 (13.6%), p=0.201 | 10 (7.5%), p=0.007 | 10 (10.9%), p=0.361 | 2 (9.1%), p=0.945 | 2 (25.0%), p=0.296 |
Symptomatics | 53 (17.7%) | 14 (15.6%), p=0.686 | 6 (9.1%), p=0.079 | 33 (22.9%), p=0.048 | 0, p=0.237 | 33 (24.6%), p=0.012 | 20 (21.7%), p=0.011 | 0, p=0.407 | 0, p=0.833 |
Antibiotics | 66 (22.0%) | 21 (23.3%), p=0.749 | 25 (37.9%), p=0.005 | 20 (13.9%), p=0.001 | 18 (40.9%), p=0.006 | 20 (14.9%), p=0.066 | 16 (17.4%), p=0.427 | 12 (54.5%), p=0.010 | 0, p=0.148 |
Phytotherapics | 48 (16.0%) | 22 (24.4%), p=0.017 | 10 (15.2%), p=0.857 | 16 (11.1%), p=0.029 | 2 (4.5%), p=0.203 | 24 (17.9%), p=0.316 | 14 (15.2%), p=0.401 | 4 (18.2%), p=0.558 | 4 (50.0%), p=0.070 |
Overall p-valuea | – | p<0.001 | p<0.001 |
Notes: p-values compare the frequency within each area versus the total frequency observed in Italy (hierarchical log-linear model).
Pearson’s chi-square test.
Abbreviations: LRTIs, lower respiratory tract infections; URTIs, upper respiratory tract infections.